Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Cholangiocarcinoma × pemigatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Myeloproliferative Disorders 1 Eosinophilia 1 Cholangiocarcinoma 1 Acrocephalosyndactylia 1

Interventions

pembrolizumab 2 pemigatinib 1 ivosidenib 1 entrectinib 1 Gemcitabine 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02924376 2025-08-14

Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)

Incyte Corporation

Phase 2 Completed

147 enrolled 22 charts 2 FDA

Gastrointestinal

Acrocephalosyndactylia, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡